tradingkey.logo

Henry Schein Inc

HSIC

68.390USD

-1.190-1.71%
Close 09/02, 16:00ETQuotes delayed by 15 min
8.34BMarket Cap
20.48P/E TTM

Henry Schein Inc

68.390

-1.190-1.71%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-02

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
47 / 280
Overall Ranking
146 / 4744
Industry
Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 17 analysts
Hold
Current Rating
73.457
Target Price
+5.57%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. The Company operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. It offers dental practice management solutions for dental and medical practitioners. It also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).
Fairly Valued
The company’s latest is 21.81, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 136.01M shares, decreasing 9.91% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 12.91M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.

Financial Health

Currency: USD Updated2025-09-02

The company's current financial score is 7.21, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 3.17B, representing a year-over-year decrease of 0.13%, while its net profit experienced a year-over-year decrease of 18.28%.

Score

Industry at a Glance

Previous score
7.21
Change
0

Financials

6.90

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

7.56

Operational Efficiency

7.23

Growth Potential

7.13

Shareholder Returns

7.21

Company Valuation

Currency: USD Updated2025-09-02

The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 22.00, which is 0.83% below the recent high of 22.18 and 3.60% above the recent low of 21.21.

Score

Industry at a Glance

Previous score
1.80
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 47/280
No Data

Earnings Forecast

Currency: USD Updated2025-09-02

The company’s current earnings forecast score is 6.59, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Henry Schein Inc is 72.00, with a high of 83.00 and a low of 55.00.

Score

Industry at a Glance

Previous score
6.59
Change
0.12

Support & Resistance

No Data

Analyst Rating

Based on 17 analysts
Hold
Current Rating
73.457
Target Price
+5.57%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
7
Median
9
Average
Company name
Ratings
Analysts
Henry Schein Inc
HSIC
17
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-02

The company’s current price momentum score is 8.87, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 72.27 and the support level at 64.34, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.94
Change
0.02

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.496
Neutral
RSI(14)
47.827
Neutral
STOCH(KDJ)(9,3,3)
45.133
Sell
ATR(14)
1.330
Low Volatility
CCI(14)
17.979
Neutral
Williams %R
56.720
Sell
TRIX(12,20)
-0.042
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
69.008
Sell
MA10
68.827
Sell
MA20
67.841
Buy
MA50
70.226
Sell
MA100
69.451
Sell
MA200
71.263
Sell

Institutional Confidence

Currency: USD Updated2025-09-02

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 112.15%, representing a quarter-over-quarter increase of 4.58%. The largest institutional shareholder is The Vanguard, holding a total of 12.91M shares, representing 10.64% of shares outstanding, with 9.95% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Kohlberg Kravis Roberts & Co. L.P.
15.65M
+30.25%
The Vanguard Group, Inc.
Star Investors
14.66M
-0.09%
Artisan Partners Limited Partnership
6.41M
-1.89%
BlackRock Institutional Trust Company, N.A.
6.26M
-3.59%
JP Morgan Asset Management
5.62M
+7.57%
State Street Global Advisors (US)
5.36M
-10.31%
American Century Investment Management, Inc.
4.60M
-4.07%
Palestra Capital Management LLC
4.00M
+51.25%
Geode Capital Management, L.L.C.
3.22M
+1.73%
Southpoint Capital Advisors LP
2.60M
--
1
2

Risk Assessment

Currency: USD Updated2025-09-02

The company's beta value is 0.86. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.77
Change
0
Beta vs S&P 500 index
0.86
VaR
+2.42%
240-Day Maximum Drawdown
+23.45%
240-Day Volatility
+32.27%
Return
Best Daily Return
60 days
+4.53%
120 days
+5.52%
5 years
+7.98%
Worst Daily Return
60 days
-7.41%
120 days
-7.41%
5 years
-8.11%
Sharpe Ratio
60 days
-0.30
120 days
-0.56
5 years
+0.17
Risk Assessment
Maximum Drawdown
240 days
+23.45%
3 years
+30.52%
5 years
+32.70%
Return-to-Drawdown Ratio
240 days
-0.09
3 years
+0.01
5 years
+0.04
Skewness
240 days
+0.08
3 years
-0.11
5 years
-0.00
Volatility
Realised Volatility
240 days
+32.27%
5 years
+27.62%
Standardised True Range
240 days
+2.79%
5 years
+2.56%
Downside Risk-Adjusted Return
120 days
-78.13%
240 days
-78.13%
Maximum Daily Upside Volatility
60 days
+23.20%
Maximum Daily Downside Volatility
60 days
+25.08%
Liquidity
Average Turnover Rate
60 days
+1.45%
120 days
+1.36%
5 years
--
Turnover Deviation
20 days
+41.54%
60 days
+21.44%
120 days
+14.25%

Peer Comparison

Currency: USD Updated2025-09-02
Henry Schein Inc
Henry Schein Inc
HSIC
6.78 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
7.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
Merit Medical Systems Inc
MMSI
7.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Boston Scientific Corp
Boston Scientific Corp
BSX
7.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
7.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
Tenet Healthcare Corp
THC
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.

KeyAI